Updates from The Motley Fool

Latest updates on Novartis from Fool.com.

Stock Performance

NVS vs. S&P 500 | 2 Year Performance
NVS 1-Day Stock Chart
NVS 5-Day Stock Chart
NVS 1-Month Stock Chart
NVS 3-Month Stock Chart
NVS 6-Month Stock Chart
NVS 1-Year Stock Chart
NVS 2-Year Stock Chart
NVS 5-Year Stock Chart
View Interactive NVS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Novartis.
Current Price: $80.11
Prev Close: $80.14
Open: $80.36
Bid: $78.35
Ask: $81.00
Day's Range: $79.99 - $80.38
52wk Range: $69.90 - $106.84
Volume: 1,276,175
Avg Vol 2,258,744
Market Cap: $191.94B
P/E (ttm): 21.66
EPS (ttm): $0.00
Div & Yield: $2.67 (2.9%)

Company Rating

What our community thinks about Novartis.
CAPS Rating 4 out of 5
1455 Outperform
43 Underperform
CAPS All Stars
366 Outperform
12 Underperform

How do you think Novartis will perform against the market?

You pick for Novartis is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Joseph Jimenez, CEO

78% Approve

Based on 61 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Novartis.

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers